Cargando…

Effects of Selenium Nanoparticles Combined With Radiotherapy on Lung Cancer Cells

OBJECTIVE: To investigate the effects of selenium nanoparticles (nano-Se) combined with radiotherapy on the proliferation, migration, invasion, and apoptosis of non-small cell lung cancer (NSCLC) A549 and NCI-H23 cells. METHODS: Nano-Se was synthesized and characterized by transmission electron micr...

Descripción completa

Detalles Bibliográficos
Autores principales: Tian, Jingxia, Wei, Xiaoying, Zhang, Weihua, Xu, Aiguo
Formato: Online Artículo Texto
Lenguaje:English
Publicado: Frontiers Media S.A. 2020
Materias:
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC7701302/
https://www.ncbi.nlm.nih.gov/pubmed/33304892
http://dx.doi.org/10.3389/fbioe.2020.598997
_version_ 1783616465874714624
author Tian, Jingxia
Wei, Xiaoying
Zhang, Weihua
Xu, Aiguo
author_facet Tian, Jingxia
Wei, Xiaoying
Zhang, Weihua
Xu, Aiguo
author_sort Tian, Jingxia
collection PubMed
description OBJECTIVE: To investigate the effects of selenium nanoparticles (nano-Se) combined with radiotherapy on the proliferation, migration, invasion, and apoptosis of non-small cell lung cancer (NSCLC) A549 and NCI-H23 cells. METHODS: Nano-Se was synthesized and characterized by transmission electron microscope (TEM), X-ray diffractometer, and Ultraviolet-visible (UV)-Vis Spectroscopy, separately. The uptake of nano-Se by lung cancer cells was detected by flow cytometry. Cell counting kit-8 (CCK-8) method was used to detect the antiproliferative activity of nano-Se combined with radiotherapy. Wound healing tests and transwell assay were used to detect the migration and invasion ability of the cells. Annexin V-fluorescein isothiocyanate (FITC)/Propidium iodide (PI) staining by flow cytometry was used to detect apoptosis. The expression of Cyclin D1 (CCND1), c-Myc, matrix metalloproteinase 2 (MMP2), MMP9, cleaved Caspase-3, and cleaved Caspase-9 were detected by Western blot. RESULTS: The average diameter of nano-Se was 24.39 nm and the wavelength of nano-Se increased with the increase of radiation dose under UV-Vis Spectroscopy. The uptake of nano-Se in lung cancer cells was increased with the increase of nano-Se concentration. The nano-Se combined with radiotherapy decreased the proliferation activity of NSCLC cell lines A549 and NCI-H23 in a dose-dependent manner (all P < 0.05). Compared with the Control group, nano-Se combined with radiotherapy could significantly inhibit the migration and invasion of lung cancer cells (all P < 0.05), and the effects of the combination of nano-Se and radiotherapy was better than that of a single application (all P < 0.05). Furthermore, nano-Se combined with radiotherapy could induce apoptosis of lung cancer cells (P < 0.05) and nano-Se combined with radiotherapy could significantly inhibit the expression of proliferation-related proteins CCND1, c-Myc, invasion and migration-related proteins MMP2 and MMP9, but conversely promoted the expression of apoptosis-related proteins cleaved caspase-3 and cleaved caspase-9. Conclusion: This study found that nano-Se combined with radiotherapy plays an anti-cancer role in lung cancer cells by inhibiting cell proliferation, migration, and invasion, as well as inducing apoptosis, suggesting that nano-Se may be used as a radiosensitizer in the clinical treatment of lung cancer, but further research is still needed.
format Online
Article
Text
id pubmed-7701302
institution National Center for Biotechnology Information
language English
publishDate 2020
publisher Frontiers Media S.A.
record_format MEDLINE/PubMed
spelling pubmed-77013022020-12-09 Effects of Selenium Nanoparticles Combined With Radiotherapy on Lung Cancer Cells Tian, Jingxia Wei, Xiaoying Zhang, Weihua Xu, Aiguo Front Bioeng Biotechnol Bioengineering and Biotechnology OBJECTIVE: To investigate the effects of selenium nanoparticles (nano-Se) combined with radiotherapy on the proliferation, migration, invasion, and apoptosis of non-small cell lung cancer (NSCLC) A549 and NCI-H23 cells. METHODS: Nano-Se was synthesized and characterized by transmission electron microscope (TEM), X-ray diffractometer, and Ultraviolet-visible (UV)-Vis Spectroscopy, separately. The uptake of nano-Se by lung cancer cells was detected by flow cytometry. Cell counting kit-8 (CCK-8) method was used to detect the antiproliferative activity of nano-Se combined with radiotherapy. Wound healing tests and transwell assay were used to detect the migration and invasion ability of the cells. Annexin V-fluorescein isothiocyanate (FITC)/Propidium iodide (PI) staining by flow cytometry was used to detect apoptosis. The expression of Cyclin D1 (CCND1), c-Myc, matrix metalloproteinase 2 (MMP2), MMP9, cleaved Caspase-3, and cleaved Caspase-9 were detected by Western blot. RESULTS: The average diameter of nano-Se was 24.39 nm and the wavelength of nano-Se increased with the increase of radiation dose under UV-Vis Spectroscopy. The uptake of nano-Se in lung cancer cells was increased with the increase of nano-Se concentration. The nano-Se combined with radiotherapy decreased the proliferation activity of NSCLC cell lines A549 and NCI-H23 in a dose-dependent manner (all P < 0.05). Compared with the Control group, nano-Se combined with radiotherapy could significantly inhibit the migration and invasion of lung cancer cells (all P < 0.05), and the effects of the combination of nano-Se and radiotherapy was better than that of a single application (all P < 0.05). Furthermore, nano-Se combined with radiotherapy could induce apoptosis of lung cancer cells (P < 0.05) and nano-Se combined with radiotherapy could significantly inhibit the expression of proliferation-related proteins CCND1, c-Myc, invasion and migration-related proteins MMP2 and MMP9, but conversely promoted the expression of apoptosis-related proteins cleaved caspase-3 and cleaved caspase-9. Conclusion: This study found that nano-Se combined with radiotherapy plays an anti-cancer role in lung cancer cells by inhibiting cell proliferation, migration, and invasion, as well as inducing apoptosis, suggesting that nano-Se may be used as a radiosensitizer in the clinical treatment of lung cancer, but further research is still needed. Frontiers Media S.A. 2020-11-16 /pmc/articles/PMC7701302/ /pubmed/33304892 http://dx.doi.org/10.3389/fbioe.2020.598997 Text en Copyright © 2020 Tian, Wei, Zhang and Xu. http://creativecommons.org/licenses/by/4.0/ This is an open-access article distributed under the terms of the Creative Commons Attribution License (CC BY). The use, distribution or reproduction in other forums is permitted, provided the original author(s) and the copyright owner(s) are credited and that the original publication in this journal is cited, in accordance with accepted academic practice. No use, distribution or reproduction is permitted which does not comply with these terms.
spellingShingle Bioengineering and Biotechnology
Tian, Jingxia
Wei, Xiaoying
Zhang, Weihua
Xu, Aiguo
Effects of Selenium Nanoparticles Combined With Radiotherapy on Lung Cancer Cells
title Effects of Selenium Nanoparticles Combined With Radiotherapy on Lung Cancer Cells
title_full Effects of Selenium Nanoparticles Combined With Radiotherapy on Lung Cancer Cells
title_fullStr Effects of Selenium Nanoparticles Combined With Radiotherapy on Lung Cancer Cells
title_full_unstemmed Effects of Selenium Nanoparticles Combined With Radiotherapy on Lung Cancer Cells
title_short Effects of Selenium Nanoparticles Combined With Radiotherapy on Lung Cancer Cells
title_sort effects of selenium nanoparticles combined with radiotherapy on lung cancer cells
topic Bioengineering and Biotechnology
url https://www.ncbi.nlm.nih.gov/pmc/articles/PMC7701302/
https://www.ncbi.nlm.nih.gov/pubmed/33304892
http://dx.doi.org/10.3389/fbioe.2020.598997
work_keys_str_mv AT tianjingxia effectsofseleniumnanoparticlescombinedwithradiotherapyonlungcancercells
AT weixiaoying effectsofseleniumnanoparticlescombinedwithradiotherapyonlungcancercells
AT zhangweihua effectsofseleniumnanoparticlescombinedwithradiotherapyonlungcancercells
AT xuaiguo effectsofseleniumnanoparticlescombinedwithradiotherapyonlungcancercells